Development of a traditional Chinese medicine‐based agent for the treatment of cancer cachexia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a traditional Chinese medicine‐based agent for the treatment of cancer cachexia
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-06-20
DOI
10.1002/jcsm.13028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle : update 2021
- (2021) Stephan Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Indoprofen prevents muscle wasting in aged mice through activation of PDK1/AKT pathway
- (2020) Hyebeen Kim et al. Journal of Cachexia Sarcopenia and Muscle
- Phytotherapy for Cachexia: Where Do We Stand?
- (2020) Kenny Kuchta et al. Frontiers in Pharmacology
- Animal models of sarcopenia
- (2020) Courtney J. Christian et al. AGING CELL
- Effects of a rhizome aqueous extract of Dioscorea batatas and its bioactive compound, allantoin in high fat diet and streptozotocin-induced diabetic mice and the regulation of liver, pancreas and skeletal muscle dysfunction
- (2020) Junnan Ma et al. JOURNAL OF ETHNOPHARMACOLOGY
- Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment
- (2019) Runzhi Zhang et al. Frontiers in Pharmacology
- A behavior-based drug screening system using a Caenorhabditis elegans model of motor neuron disease
- (2019) Kensuke Ikenaka et al. Scientific Reports
- Modeling Human Cancer-induced Cachexia
- (2019) Erin E. Talbert et al. Cell Reports
- UNC-120/SRF independently controls muscle aging and lifespan in Caenorhabditis elegans
- (2018) Adeline Mergoud dit Lamarche et al. AGING CELL
- Cancer-associated cachexia
- (2018) Vickie E. Baracos et al. Nature Reviews Disease Primers
- Effects of Rhizome Extract of Dioscorea batatas and Its Active Compound, Allantoin, on the Regulation of Myoblast Differentiation and Mitochondrial Biogenesis in C2C12 Myotubes
- (2018) Junnan Ma et al. MOLECULES
- Prevention of oral carcinogenesis in rats by Dracaena cinnabari resin extracts
- (2018) Nashwan Al-Afifi et al. Clinical Oral Investigations
- Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition
- (2018) Tingting Fang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Targeting breast cancer stem cells by novel HDAC3-selective inhibitors
- (2017) Hao-Yu Hsieh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs
- (2017) Wooseong Kim et al. Expert Opinion on Drug Discovery
- Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice
- (2017) Hikari Takeshita et al. Scientific Reports
- Comparative Analysis of Proteins with Stimulating Activity on Ovarian Estradiol Biosynthesis from Four Different Dioscorea Species in vitro Using Both Phenotypic and Target-based Approaches: Implication for Treating Menopause
- (2016) J. Lu et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Screening lifespan-extending drugs in Caenorhabditis elegans via label propagation on drug-protein networks
- (2016) Hui Liu et al. BMC Systems Biology
- Moutan cortex extract exerts protective effects in a rat model of cardiac ischemia/reperfusion
- (2016) Hong Dan et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Use of ghrelin in cachexia syndrome: a systematic review of clinical trials
- (2016) Jéssica V. Mansson et al. NUTRITION REVIEWS
- Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases
- (2015) Xi Chen et al. Chemistry Central Journal
- A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia
- (2015) Danielle N. Seto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: An in vitro and in vivo study
- (2015) LEI YUAN et al. ONCOLOGY REPORTS
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- C. elegans in high-throughput drug discovery
- (2013) Linda P. O'Reilly et al. ADVANCED DRUG DELIVERY REVIEWS
- Functional Aging in the Nervous System Contributes to Age-Dependent Motor Activity Decline in C. elegans
- (2013) Jie Liu et al. Cell Metabolism
- An In Vivo C. elegans Model System for Screening EGFR-Inhibiting Anti-Cancer Drugs
- (2012) Young-Ki Bae et al. PLoS One
- Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse
- (2010) Paola Aulino et al. BMC CANCER
- Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
- (2010) James A. Carson et al. EXERCISE AND SPORT SCIENCES REVIEWS
- C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: Relevance to disease and ageing?
- (2010) Adam P. Sharples et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Interleukin-1 stimulates catabolism in C2C12 myotubes
- (2009) Wei Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now